Screening cytokine/chemokine profiles in serum and organs from an endotoxic shock mouse model by LiquiChip

[1]  S. Oda,et al.  Interleukin-6 Levels Act as a Diagnostic Marker for Infection and a Prognostic Marker in Patients with Organ Dysfunction in Intensive Care Units , 2016, Shock.

[2]  Adil Rafiq Rather,et al.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) , 2015 .

[3]  G. Camussi,et al.  Interaction between systemic inflammation and renal tubular epithelial cells. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  W. Leonard,et al.  Potential role of myeloid cell/eosinophil-derived IL-17 in LPS-induced endotoxin shock. , 2014, Biochemical and biophysical research communications.

[5]  Edward A. Panacek,et al.  Epidemiology of the Systemic Inflammatory Response Syndrome (SIRS) in the Emergency Department , 2014, The western journal of emergency medicine.

[6]  C. Natanson,et al.  Antitumor Necrosis Factor Therapy Is Associated With Improved Survival in Clinical Sepsis Trials: A Meta-Analysis* , 2013, Critical care medicine.

[7]  J. Vincent,et al.  Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial. , 2013, JAMA.

[8]  E. Seeley,et al.  Inflection points in sepsis biology: from local defense to systemic organ injury. , 2012, American journal of physiology. Lung cellular and molecular physiology.

[9]  S. Kingsmore,et al.  Discriminative value of inflammatory biomarkers for suspected sepsis. , 2012, The Journal of emergency medicine.

[10]  K. Huntoon,et al.  Interleukin-6 in Surgery, Trauma, and Critical Care Part II: Clinical Implications , 2011, Journal of intensive care medicine.

[11]  R. Tompkins,et al.  EARLY ELEVATION IN RANDOM PLASMA IL-6 AFTER SEVERE INJURY IS ASSOCIATED WITH DEVELOPMENT OF ORGAN FAILURE , 2010, Shock.

[12]  B. Ryffel,et al.  Crucial Role of TNF Receptors 1 and 2 in the Control of Polymicrobial Sepsis1 , 2009, The Journal of Immunology.

[13]  S. Zeerleder,et al.  International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients , 2006, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[14]  J. Marshall,et al.  Biomarkers of sepsis , 2006, Current infectious disease reports.

[15]  S. Akira,et al.  Pathogen Recognition and Innate Immunity , 2006, Cell.

[16]  P. Wadhwa,et al.  Validation and comparison of luminex multiplex cytokine analysis kits with ELISA: determinations of a panel of nine cytokines in clinical sample culture supernatants. , 2005, Journal of reproductive immunology.

[17]  K. Tracey,et al.  The "cytokine profile": a code for sepsis. , 2005, Trends in molecular medicine.

[18]  Steven B. Johnson,et al.  Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab′)2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels* , 2004, Critical care medicine.

[19]  S. Cuzzocrea,et al.  Effect of Methylguanidine in a Model of Septic Shock Induced by LPS , 2004, Free radical research.

[20]  R. Bellomo,et al.  Do circulating cytokines really matter in sepsis? , 2003, Kidney international. Supplement.

[21]  D. Peritt,et al.  A novel monoclonal antibody screening method using the Luminex-100 microsphere system. , 2002, Journal of immunological methods.

[22]  T. van der Poll,et al.  Immunotherapy of sepsis , 2001 .

[23]  D. Vignali.  Multiplexed particle-based flow cytometric assays. , 2000, Journal of immunological methods.

[24]  P. Ricciardi-Castagnoli,et al.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.

[25]  S. Vogel,et al.  Pulmonary and Hepatic Gene Expression following Cecal Ligation and Puncture: Monophosphoryl Lipid A Prophylaxis Attenuates Sepsis-Induced Cytokine and Chemokine Expression and Neutrophil Infiltration , 1998, Infection and Immunity.

[26]  S. Nasraway,et al.  Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock , 1998, The Lancet.

[27]  C. Natanson,et al.  Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment. , 1997, Critical care medicine.

[28]  R. Dantzer,et al.  Adrenalectomy enhances pro-inflammatory cytokines gene expression, in the spleen, pituitary and brain of mice in response to lipopolysaccharide. , 1996, Brain research. Molecular brain research.

[29]  K. Murphy,et al.  Role of cytokines in determining T-lymphocyte function. , 1994, Current opinion in immunology.

[30]  A. Cerami,et al.  Detection of circulating tumor necrosis factor after endotoxin administration. , 1988, The New England journal of medicine.

[31]  B. Meyrick,et al.  Endotoxin and lung injury. , 1986, The American review of respiratory disease.

[32]  T. van der Poll,et al.  Host-pathogen interactions in sepsis. , 2008, The Lancet. Infectious diseases.

[33]  R. Tompkins,et al.  Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. , 1990, The Journal of infectious diseases.